(1)
Ong , T. D.; Phùng , L. T.; Đỗ, Q. T.; Đỗ, T. M.; Nguyễn, T. V. COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH FIRST-LINE AFATINIB VERSUS OSIMERTINIB IN NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION IN VIETNAM. VMJ 2023, 527.